ong Kong Center for Neurodegenerative Diseases (HKCeND) participated in the highly anticipated InnoHK Summit 2023, held at Hong Kong Science Park on 6 December 2023.
Prof. Nancy Ip, Center Director of HKCeND, took the stage to share the groundbreaking research and development (R&D) breakthroughs in the field of Alzheimer’s disease. The inspiring presentation of Prof. Ip shed light on the key advancements of the Center in developing innovative diagnostic tests and therapeutic strategies, aimed at addressing the global health threat of Alzheimer’s disease, which is associated with an aging population.
The interactive booths at the summit created a vibrant atmosphere, allowing the HKCeND team to engage in insightful exchanges and showcase their R&D achievements to visitors.
“This summit not only provided an exceptional platform for us to share our impactful R&D breakthroughs, but also facilitated us to exchange with world-class experts, innovators, and industry leaders. It further fuels our drive to revolutionize diagnostic and therapeutic solutions for Alzheimer’s disease,” said Prof. Ip.
As a research center under the InnoHK initiative, the Center remains committed to fostering global research collaboration, driving scientific and technological advancements, and translating R&D outcomes into tangible solutions.
“With a relentless pursuit of innovation and a top-notch team, we strive to bring impactful healthcare solutions that benefit society,” added Prof. Ip.
The InnoHK Summit 2023, organized by the Innovation and Technology Commission and the Hong Kong Science and Technology Parks Corporation, attracted more than 800 prominent academics, scientists, representatives of renowned institutes and industry leaders from Hong Kong and around the world. The summit showcased the latest innovations and developments of 28 InnoHK centers and unpacked innovation and technology (I&T) trends and opportunities through panel discussions with top experts from the industry and academia.
Related News
Event
Press Release